Organto Foods Announces Investor Relations Agreements and Grant of Stock Options
Organto Foods Inc. (TSXV:OGO)(OTC PINK:OGOFF) has announced multiple investor relations initiatives and stock option grants. The company has entered into an agreement with 12538938 Canada Inc., controlled by director Peter Damouni, for strategic communication services at C$7,500 monthly until March 31, 2026. The agreement includes 700,000 stock options at $0.20 per share.
Additionally, Organto has granted 3,850,000 stock options to directors, officers, and employees at $0.20 per share, expiring April 17, 2029. The company has also engaged Atrium Research for issuer-paid research services at C$3,000 monthly for 12 months to produce research reports based on public information.
Organto Foods Inc. (TSXV:OGO)(OTC PINK:OGOFF) ha annunciato diverse iniziative di relazioni con gli investitori e concessioni di opzioni su azioni. La società ha stipulato un accordo con 12538938 Canada Inc., controllata dal direttore Peter Damouni, per servizi di comunicazione strategica al costo di 7.500 C$ al mese fino al 31 marzo 2026. L'accordo prevede inoltre 700.000 opzioni su azioni a 0,20 C$ per azione.
Inoltre, Organto ha concesso 3.850.000 opzioni su azioni a direttori, dirigenti e dipendenti al prezzo di 0,20 C$ per azione, con scadenza il 17 aprile 2029. La società ha anche incaricato Atrium Research per servizi di ricerca a pagamento dall'emittente al costo di 3.000 C$ mensili per 12 mesi, al fine di produrre report di ricerca basati su informazioni pubbliche.
Organto Foods Inc. (TSXV:OGO)(OTC PINK:OGOFF) ha anunciado varias iniciativas de relaciones con inversionistas y concesiones de opciones sobre acciones. La empresa ha firmado un acuerdo con 12538938 Canada Inc., controlada por el director Peter Damouni, para servicios de comunicación estratégica por C$7,500 mensuales hasta el 31 de marzo de 2026. El acuerdo incluye 700,000 opciones sobre acciones a $0.20 por acción.
Además, Organto ha otorgado 3,850,000 opciones sobre acciones a directores, funcionarios y empleados a $0.20 por acción, con vencimiento el 17 de abril de 2029. La empresa también contrató a Atrium Research para servicios de investigación pagados por el emisor por C$3,000 mensuales durante 12 meses para elaborar informes de investigación basados en información pública.
Organto Foods Inc. (TSXV:OGO)(OTC PINK:OGOFF)는 여러 투자자 관계 활동과 주식 옵션 부여를 발표했습니다. 회사는 이사 Peter Damouni가 통제하는 12538938 Canada Inc.와 전략적 커뮤니케이션 서비스 계약을 체결했으며, 2026년 3월 31일까지 월 C$7,500의 비용이 발생합니다. 이 계약에는 주당 $0.20에 700,000주의 주식 옵션이 포함되어 있습니다.
추가로, Organto는 이사, 임원 및 직원에게 주당 $0.20에 3,850,000주의 주식 옵션을 부여했으며, 만료일은 2029년 4월 17일입니다. 또한 회사는 Atrium Research와 12개월간 월 C$3,000의 발행인 비용으로 연구 보고서를 공공 정보를 기반으로 작성하는 연구 서비스 계약을 체결했습니다.
Organto Foods Inc. (TSXV:OGO)(OTC PINK:OGOFF) a annoncé plusieurs initiatives en relations investisseurs et des attributions d’options d’achat d’actions. La société a conclu un accord avec 12538938 Canada Inc., contrôlée par le directeur Peter Damouni, pour des services de communication stratégique à 7 500 C$ par mois jusqu’au 31 mars 2026. L’accord inclut 700 000 options d’achat d’actions à 0,20 $ par action.
De plus, Organto a octroyé 3 850 000 options d’achat d’actions à des administrateurs, dirigeants et employés au prix de 0,20 $ par action, expirant le 17 avril 2029. La société a également engagé Atrium Research pour des services de recherche payés par l’émetteur à 3 000 C$ par mois pendant 12 mois afin de produire des rapports de recherche basés sur des informations publiques.
Organto Foods Inc. (TSXV:OGO)(OTC PINK:OGOFF) hat mehrere Initiativen im Bereich Investor Relations und die Gewährung von Aktienoptionen bekannt gegeben. Das Unternehmen hat eine Vereinbarung mit 12538938 Canada Inc., die von Direktor Peter Damouni kontrolliert wird, über strategische Kommunikationsdienstleistungen zu monatlichen Kosten von 7.500 C$ bis zum 31. März 2026 abgeschlossen. Die Vereinbarung umfasst 700.000 Aktienoptionen zu je 0,20 C$.
Zusätzlich hat Organto 3.850.000 Aktienoptionen an Direktoren, Führungskräfte und Mitarbeiter zu je 0,20 C$ pro Aktie gewährt, die am 17. April 2029 verfallen. Das Unternehmen hat außerdem Atrium Research für vom Emittenten bezahlte Forschungsdienstleistungen engagiert, die für 12 Monate mit monatlich 3.000 C$ vergütet werden, um auf Basis öffentlicher Informationen Forschungsberichte zu erstellen.
- None.
- None.
VANCOUVER, BC, AND BREDA, THE NETHERLANDS / ACCESS Newswire / April 17, 2025 / Organto Foods Inc. (TSXV:OGO)(OTC PINK:OGOFF) ("Organto" or the "Company") today announced that it has entered into investor relations agreements and issued stock options to certain directors, officers and employees of the Company.
Engagement of 125389938 Cananda Inc. for Investor Relations Services
The Company has entered into an investor relations agreement (the "Agreement") with 12538938 Canada Inc. ("12538938"), a private company controlled by Peter Damouni, a director of the Company. Pursuant to the Agreement, 12538938 has agreed to provide strategic communication services to the Company, in consideration for a fee of C
The Agreement is considered to be a "related party transaction" as defined under Multilateral Instrument 61-101 ("MI 61-101") and is exempt from the formal valuation and minority shareholder approval requirements of MI 61-101 since, at the time was agreed to, neither the fair market of the subject matter of, nor the fair market value of the consideration for, the transaction, exceeds
Grant of Stock Options
The Company has also granted stock options (the "Options") exercisable to acquire up to 3,850,000 Common Shares to directors, officers and employees of the Company at a price of
The Options and Consultant Options were granted pursuant to the Company's stock option plan which was last approved by shareholders at the annual meeting of shareholders on March 12, 2025 and remain subject to the approval of the TSX Venture Exchange.
Engagement of Atrium Research Corporation
Organto also announces that it has engaged the services of Toronto based Atrium Research Corporation ("Atrium"), a provider of issuer paid research, effective immediately. Atrium will produce a number of research reports based on publicly available information, industry data, and discussions with management to assist the Company in presenting its investment case to potential investors. In exchange for its services, Atrium will receive cash compensation in the amount of C
ON BEHALF OF THE BOARD
Steve Bromley
Chairman and CEO
For more information, contact:
Investor Relations
John Rathwell, Senior Vice President, Investor Relations & Corporate Development
647 629 0018
info@organto.com
ABOUT ORGANTO
Organto is a leading provider of branded, private label, and distributed organic and non-GMO fruit and vegetable products using a strategic asset-lighter business model to serve a growing socially responsible and health-conscious consumers. Organto's business model is rooted in its commitment to sustainable business practices focused on environmental responsibility and a commitment to the communities where it operates, its people, and its shareholders.
FORWARD LOOKING STATEMENTS
This news release may include certain forward-looking information and statements, as defined by law, including without limitation, Canadian securities laws and the "safe harbor" provisions of the US Private Securities Litigation Reform Act ("forward-looking statements"). In particular, and without limitation, this news release contains forward-looking statements respecting the Company's investor relations service providers, their activities and the costs related thereto. Forward-looking statements are based on a number of assumptions that may prove to be incorrect, including, without limitation, the assumption that the Company will be successful with its planned investor relations activities and that all requisite TSX Venture Exchange approvals will be received. There can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements. Factors that could cause actual results to differ materially from those anticipated in forward-looking statements in this news release include, among others, uncertainty regarding the regulatory risks; risks related to market volatility and economic conditions; risks related to unforeseen delays; and risks that necessary financing will be unavailable when needed. For further information on these and other risks and uncertainties that may affect the Company's business, see the "Risks and Uncertainties" and "Forward-Looking Statements" sections of the Company's annual and interim management's discussion and analysis filings with the Canadian securities regulators, which are available under the Company's profile at www.sedarplus.ca. Except as required by law, Organto does not assume any obligation to release publicly any revisions to forward-looking statements contained in this news release to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release.
SOURCE: Organto Foods, Inc.
View the original press release on ACCESS Newswire
FAQ
What are the terms of Organto Foods' (OGOFF) new stock options grant in April 2025?
How much is Organto Foods (OGOFF) paying for investor relations services in 2025?
What is the vesting schedule for Organto Foods' (OGOFF) consultant stock options?
When do Organto Foods' (OGOFF) new investor relations agreements expire?
